Loading market data...
Latest Top News
Show more
Wockhardt Posts Rs 780 Million Profit In September Quarter, Revenue At Rs 7.82 Billion
Wockhardt Ltd reported a consolidated net profit of Rs 780 million for the September 2025 quarter, supported by strong performance in its global pharmaceutical operations. Revenue from operations stood at Rs 7.82 billion, reflecting growth in exports, specialty drugs, and strategic cost optimization across key markets.
Stay Ahead – Explore Now! Network People Services Technologies Secures ₹1.68 Billion Windfall: Central Bank of India Places Major Order






